Mr Gregory A. Schernecke > Dechert LLP > Philadelphia, United States > Lawyer Profile
Dechert LLP Offices
CIRCA CENTRE, 2929 ARCH STREET
PHILADELPHIA, PA 19104-2808
PENNSYLVANIA
United States
- Firm Profile
- Go to...
Mr Gregory A. Schernecke
Work Department
Corporate & Securities
Career
Gregory A. Schernecke focuses his practice on mergers and acquisitions, with a particular emphasis on private equity; corporate finance and general corporate matters, including public company reporting and governance issues.
Mr. Schernecke represents private equity and strategic buyers and sellers and their portfolio companies in merger and acquisition transactions across a wide range of industry sectors, including travel and hospitality, healthcare, technology, consumer products, financial services and asset management and industrial manufacturing. He also represents companies and investment banks in cross border public and private financing transactions and securities offerings of equity and debt.
Memberships
Philadelphia Bar Association Young Lawyers Division
Education
Davidson College, B.A., 2003; Temple University Beasley School of Law, J.D., 2008, magna cum laude
Top Tier Firm Rankings
- Environment > Environment: transactional
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Antitrust > Civil litigation/class actions: defense
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate finance
- Finance > Structured finance: securitization
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > E-discovery
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- International trade and national security > Customs, export controls and economic sanctions
- Dispute resolution > International arbitration
- Tax > International tax
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (full coverage)
- Finance > Capital markets: high-yield debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Investment fund formation and management > Alternative/hedge funds
- Dispute resolution > Financial services litigation
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)